• Chart
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • News
  • FAQs
    1. Home
    2. Stocks
    3. Pghh Share Price

    Procter & Gamble Hygiene & Healthcare Share PriceProcter & Gamble Hygiene & Healthcare

    Large Cap 3.1k Result
    ₹13767.6
    -227.05 (-1.62%)
    As on 06 June, 2023 | 22:51 BSE: 500459 NSE: PGHH
    Announcements Dividends

    Procter & Gamble Hygiene & Healthcare Performance

    Day Range

    • Low
    • High
    13767.6

    52 Week Range

    • Low
    • High
    13767.6
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Procter & Gamble Hygiene & Healthcare

    Start SIP

    Procter & Gamble Hygiene & Healthcare Share Price

    • Over 1 Month -1.31%
    • Over 3 Month -1.49%
    • Over 6 Month -3.45%
    • Over 1 Year -2.29%

    Procter & Gamble Hygiene & Healthcare Key Statistics

    P/E Ratio 78.5
    PEG Ratio -35.9
    Market Cap Cr 44,691
    Price to Book Ratio 60.6
    EPS 177.8
    Dividend 1.1
    Relative Strength Index 51.87
    Money Flow Index 35.95
    MACD Signal -73.06
    Average True Range 233.53

    Procter & Gamble Hygiene & Healthcare Investment Rating

    • Master Rating:

    • P&G.Hygiene & Hlth.Care has an operating revenue of Rs. 3,841.75 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 20% is great, ROE of 78% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its key moving averages, around 1% and 0% from 50DMA and 200DMA. It needs to stay above these levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 84 which is a GOOD score indicating consistency in earnings, a RS Rating of 37 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 122 indicates it belongs to a poor industry group of Cosmetics/Personal Care and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Procter & Gamble Hygiene & Healthcare Financials
    IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 8811,1371,041756889
    Operating Expenses Qtr Cr 734847831709808
    Operating Profit Qtr Cr 14929021467165
    Depreciation Qtr Cr 1514141413
    Interest Qtr Cr 44117
    Tax Qtr Cr -1974511548
    Net Profit Qtr Cr 16520715443103

    Procter & Gamble Hygiene & Healthcare Technicals

    EMA & SMA

    Current Price
    ₹13767.6
    -227.05 (-1.62%)
    • Bullish Moving Average
    • ___
    • 10
    • Bearish Moving Average
    • ___
    • 6
    • 20 Day
    • ₹13697.79
    • 50 Day
    • ₹13767.31
    • 100 Day
    • ₹13828.4
    • 200 Day
    • ₹13914.54
    • 20 Day
    • ₹13674.2
    • 50 Day
    • ₹13828.31
    • 100 Day
    • ₹13788.77
    • 200 Day
    • ₹13977.51

    Procter & Gamble Hygiene & Healthcare Resistance and Support

    PIVOT
    ₹13877.97
    Resistance
    First Resistance ₹14157.64
    Second Resistance ₹14320.62
    Third Resistance ₹14600.29
    RSI 51.87
    MFI 35.96
    MACD Single Line -73.06
    MACD -34.93
    Support
    First Resistance ₹13714.99
    Second Resistance ₹13435.32
    Third Resistance ₹13272.34

    Procter & Gamble Hygiene & Healthcare Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 6,132 376,505 61.4
    Week 7,100 486,891 68.58
    1 Month 15,253 1,252,881 82.14
    6 Month 6,873 462,821 67.34

    Procter & Gamble Hygiene & Healthcare Result Highlights

    Procter & Gamble Hygiene & Healthcare Synopsis

    NSE-Cosmetics/Personal Care

    P&G Hygiene&Health is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 3900.92 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 30/06/2022. Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971.
    Market Cap 44,691
    Sales 3,842
    Shares in Float 0.94
    No of funds 125
    Yield 1.05
    Book Value 60.59
    U/D Vol ratio 1.3
    LTDebt / Equity
    Alpha -0.01
    Beta 0.24

    Procter & Gamble Hygiene & Healthcare

    Owner NameMar-23Dec-22Sep-22Jun-22
    Promoters 70.64%70.64%70.64%70.64%
    Mutual Funds 7.93%7.89%7.56%7.47%
    Insurance Companies 7.39%7.21%6.8%6.43%
    Foreign Portfolio Investors 1.05%1.12%1.68%2.03%
    Financial Institutions/ Banks 0.01%0.01%0.01%0.01%
    Individual Investors 10.15%10.22%10.34%10.37%
    Others 2.83%2.91%2.97%3.05%

    Procter & Gamble Hygiene & Healthcare Management

    Name Designation
    Mr. Chittranjan Dua Chairman & Ind.Director
    Mr. L V Vaidyanathan Managing Director
    Mr. Krishnamurthy Iyer Independent Director
    Ms. Meena Ganesh Independent Director
    Mr. Anil Kumar Gupta Independent Director
    Mr. Gurcharan Das Independent Director
    Mr. Karthik Natarajan Non Executive Director
    Ms. Sonali Dhawan Non Executive Director
    Mr. Gagan Sawhney Non Executive Director
    Mr. Pramod Agarwal Non Executive Director
    Mr. Ghanashyam Hegde Executive Director & Company Secretary

    Procter & Gamble Hygiene & Healthcare Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Procter & Gamble Hygiene & Healthcare Corporate Action

    Date Purpose Remarks
    2023-05-10 Quarterly Results
    2023-01-31 Quarterly Results & Interim Dividend
    2022-11-02 Quarterly Results
    2022-08-23 Audited Results & Final Dividend
    2022-04-28 Quarterly Results
    Date Purpose Remarks
    2023-02-08 INTERIM Rs.80.00 per share(800%)Interim Dividend
    2022-02-09 INTERIM Rs.95.00 per share(950%)Interim Dividend
    2021-05-12 SPECIAL Rs.150.00 per share (1500%) Special Interim Dividend
    2021-02-11 INTERIM Rs.85.00 per share(850%)Interim Dividend

    Procter & Gamble Hygiene & Healthcare MF Shareholding

    Name Amount(cr)
    SBI Equity Hybrid Fund Regular Payout Inc Dist cum Cap Wdrl 56300
    ICICI Prudential Bluechip Fund Growth 35877
    SBI Focused Equity Fund Growth 27962
    SBI Magnum Midcap Fund Regular Growth 9370
    SBI Conservative Hybrid Fund Regular Growth 7569

    About Company

    Procter & Gamble Hygiene and Healthcare Ltd. is a subsidiary of Procter & Gamble (P&G). They are one of India's fastest-growing FMCG companies with a portfolio of brands such as Vicks & Whisper. 

    Vicks has been India's leading over-the-counter (OTC) Cough and Cold Brand since its launch in 1952. The products under this brand include Vicks Action500+, Vicks VapoRub, Vicks Cough Drops, Vicks Formula 44 Cough Syrup and Vicks Inhaler.

    Whisper is another top feminine hygiene brand with a product portfolio consisting of Whisper Maxi Regular, Whisper Maxi XL Wings, Whisper Ultra with Wings and Whisper Choice.

    It’s manufacturing facilities are located in Goa and Baddi in Himachal Pradesh, apart from it the company also has third-party manufacturing plants across India.

    Business Verticals

    P&G Hygiene and Healthcare Ltd. is engaged in manufacturing, distributing and selling personal health care products. It operates primarily in two segments: Feminine Care Business (Whisper) and Health Care Business (Vicks).

    Whisper continues to be the market leader in the feminine care business. The "Comfort & Soft" segment, with the launch of Whisper Choice Aloe Vera's longer length, and the upgrade of their flagship Ultra and Choice portfolio, have transcended customer experience.

    In the healthcare business, Procter & Gamble Hygiene and Healthcare Ltd. continued to win despite the challenges due to COVID-19 with the growth of Vicks' portfolio. Vicks 3-in-1 throat lozenges boosted the growth of this segment due to increased demand with world-class communication across all our sub-brands and superior go-to-market strategy. 

    Milestones

    1964 - On July 20, the Company was incorporated in Mumbai. 

    1979 -  The premier product of the company Vicks Action 500 was launched

    1985 -
    In September, the Company's herbal plant in Annaram, Andhra Pradesh's Medak district, was commissioned to produce herbal and other natural ingredient products. 
    Procter & Gamble Co. acquired Richardson-Vicks Inc. in October, and as a result, Richardson Hindustan Ltd. (RHL) became a Procter & Gamble Co. affiliate. Thus, the name of the Company was changed from Richardson Hindustan Ltd. to Procter & Gamble India Ltd. on April 4, 1988.

    1992 - The Company introduced Whisper Extra long and Whisper Extra Large.

    1993 - The Company High-Quality Whisper with Wings was introduced. 

    1995 -
    Vicks Vitamin 'C' is a premium line of drops introduced by the Company. 
    Whisper Extra Dry, a high-performance sanitary protection product, was introduced by the Company.
    The Company ventured to set up a state-of-the-art technology healthcare plant in Goa.

    1996 - The Company introduced a test market for Vicks Vaporub Super Balm. 

    1998 - Procter & Gamble India Ltd. has now become Procter & Gamble Hygiene and Health Care Ltd.

    2000 -
    The Company introduced a new brand, Tampax, to the Indian Sanitary napkin market.
    Vicks cough drop was reintroduced in a new 2.5 gm blue back.
    Vicks Plus medicated lozenges made their way in India.
    Gary W. Cofer, country manager, Procter and Gamble, India, is the new managing director of Procter and Gamble Hygiene and Healthcare Ltd. w.e.f. September 1.
    Doctoranywhere.com and Procter & Gamble Hygiene & Healthcare join hands.
    Vicks Action 5000 was reintroduced in an attractive Blue international pack.

    2001 -
    The Company launched a Whisper Ultra Day-Night pack for the first time in Tamil Nadu, India.
    They kickstarted an outdoor advertising campaign for Vicks Plus medicated lozenges.

    2002 - P&G Hygiene and Health Care Ltd. announced that Mr. Gary Cofer would step down as Managing Director on April 1, 2002. Mr. Shantanu Khosla will be named Managing Director.

    2003 - The Company launched a new VICKS Formula 44 cough syrup.

    2004 -  'Whisper Choice' makes its entry in Tamil Nadu, Andhra Pradesh, Kerala and Karnataka with a pack of 10 pads priced at Rs 26 as a test market launch.

    2019 - The Company was awarded the Packaging Innovation Awards 2019 and Best Workplaces for Innovators 2019.

    2020 - The Company was awarded Top 25 Most Innovative Client Companies 2020.

    Procter & Gamble Hygiene & Healthcare FAQs

    What is Share Price of Procter & Gamble Hygiene & Healthcare ?

    Procter & Gamble Hygiene & Healthcare share price is ₹13767 As on 06 June, 2023 | 22:37

    What is the Market Cap of Procter & Gamble Hygiene & Healthcare ?

    The Market Cap of Procter & Gamble Hygiene & Healthcare is ₹44690.6 Cr As on 06 June, 2023 | 22:37

    What is the P/E ratio of Procter & Gamble Hygiene & Healthcare ?

    The P/E ratio of Procter & Gamble Hygiene & Healthcare is 78.5 As on 06 June, 2023 | 22:37

    What is the PB ratio of Procter & Gamble Hygiene & Healthcare ?

    The PB ratio of Procter & Gamble Hygiene & Healthcare is 60.6 As on 06 June, 2023 | 22:37

    What were the Company's most recent reported sales and net income?

    Procter & Gamble Hygiene and Health Care Ltd. recorded net sales of INR 3574 as of Jun 21, 2022.

    What is the future of the Company's shares?

    Procter & Gamble Hygiene and Healthcare Ltd. stock is an excellent long-term (1-year) investment with an expected long-term increase in the price.

    How to buy shares of Procter & Gamble Hygiene and Healthcare Ltd.?

    The Company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Enter Mobile Number

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from NSDL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.

    Start Investing Now!

    Open Free Demat Account in 5 mins

    Enter Valid Mobile Number